B&C BIOPHARM
B&C Biopharm (B&C) is a biopharmaceutical venture company. The company discovers and develops pharmaceutical products for the treatment of the infectious diseases. B&C’s product portfolio includes NS5B inhibitors, BC2125, BC2329, NS3 inhibitors, PPI inhibitors, and antifungal agents. The company conducts research to develop therapeutics for Hepatitis C, NS5B RNA polymerase, and NS3 helicase, among others. Its Korean’s patents for drug discoveries are 446669, 516434, and 516433 among others. The company has strategic alliances with various organizations such as Yuhan Pharm, Equis Pharm, Daewon Pharm, Wayne State University, and Korea University Medical School. It has license and development agreement with XTL Biopharmaceuticals. B&C is headquartered in Yeongtong-gu, Gyeonggi-do, Korea.
B&C BIOPHARM
Industry:
Biotechnology Medical Pharmaceutical
Address:
Gyeongju, Kyongsang-bukto, South Korea
Country:
South Korea
Website Url:
http://www.bncbio.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Mobile Non Scaleable Content Nginx Baidu Analytics Peg Technic 51.la XZ.com
Similar Organizations
Biok Biology
Biok Biology is a biopharmaceutical business operation platform.
i2 Pharmaceuticals
i2 Pharmaceuticals, a biopharmaceutical company.
InnoCore Pharmaceuticals
InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company.
Official Site Inspections
http://www.bncbio.com
- Host name: 124.205.76.34.bc.googleusercontent.com
- IP address: 34.76.205.124
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
